Utility of CT Fluoroscopy Guidance During Percutaneous Sacroplasty With Quality of Life Assessment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00765258|
Recruitment Status : Completed
First Posted : October 2, 2008
Last Update Posted : August 21, 2013
To examine, through retrospective and prospective chart review, the difference in pain and mobility, pre and post treatment, as assessed by the patient's completion of the VAS pain scale and Roland Morris Disability Questionnaire (RMDQ).
CT fluoroscopy guidance during percutaneous sacroplasty is an effective treatment for sacro-iliac insufficiency fractures resulting in rapid reduction of pain and improved mobility in patients. This can be effectively assessed using the VAS pain scale and RMDQ both pre and post procedure.
|Condition or disease|
|Sacro-iliac Insufficiency Fractures|
|Study Type :||Observational|
|Actual Enrollment :||14 participants|
|Official Title:||Utility of CT Fluoroscopy Guidance During Percutaneous Sacroplasty With Quality of Life Assessment|
|Study Start Date :||January 2008|
|Actual Primary Completion Date :||May 2012|
|Actual Study Completion Date :||February 2013|
- Reduction of pain and improved mobility in patients post percutaneous sacroplasty effectively assessed using the VAS pain scale and RMDQ both pre and post procedure. [ Time Frame: 2008-2012 ]The average pre-treatment VAS score was significantly improved after sacroplasty in patients with sacral insufficiency fractures.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00765258
|United States, Wisconsin|
|Medical College of Wisconsin / Froedtert Hospital|
|Milwaukee, Wisconsin, United States, 53226|
|Principal Investigator:||Sean M Tutton, MD||Medical College of Wisconsin|